snow
Events - Slide 1 Events - Slide 2 Events - Slide 3 Events - Slide 4

Welcome to Retina Specialists Northwest

Dedicated to delivering compassionate excellence in retinal and inflammatory eye disease always.

Retina Specialists Northwest, PLLC is an ophthalmic subspecialty practice focused on Retina and Uveitis. The practice philosophy is summarized in the company motto: Compassionate Excellence Always.

Board certified eye physician and surgeon, Dr. Brenda Myers-Powell

Dr. Myers-Powell and her staff are committed to delivering the best in personalized retinal care efficiently and effectively. Our pledge is to understand you as a whole and to provide the best available medical and surgical treatment tailored to your needs. We are centrally located between Seattle and Tacoma, at West Campus in Federal Way, strategically positioned to deliver quality care to residents within and outside the metropolitan areas. Our office is easily accessible from I-5, Hwy-18, Hwy-167, and Hwy-99. For your convenience, we are open most Saturdays.

We utilize the latest technology as well as clinical expertise to diagnose and manage all retinal and inflammatory disorders with particular attention to Retinal Tear and Detachment, Disorders of the Vitreous, Macular Holes, Diabetic Retinopathy, Age-related Macular Degeneration, Retinal Vascular Disease, Macular Edema, Scleritis, and vision-threatening Uveitis.

Ultra-Widefield Multifocal Electroretinography and Visual Evoked Potentials

Retina Specialists Northwest is proud to announce the implementation of Diagnosys Ultra-Widefield Multifocal Electroretinography (mfERG) and Visual Evoked Potentials (VEP) as part of our service. This diagnostic tool can significantly benefit those with retinal and optic nerve disease.

Retina Specialists Northwest has invested in elevating the level of care in the Puget Sound area by providing a valuable service that had previously been unavailable in our community.

The mfERG can objectively assess cone dysfunction and macular disease facilitating diagnosis and assessment of progression of macular disorders such as Retinal Dystrophy, ARMD, Diabetic Retinopathy and Drug Toxicity. The AAO has listed mfERG as a critical test modality for screening for Plaquenil Toxicity.

VEP can assess optic nerve function, improving the diagnosis and management of Optic Neuritis and Optic Neuropathy. This is particularly useful in Multiple Sclerosis.

Our Federal Way office will provide this service at your patients' convenience.

Call (253) 517-3334 to schedule an appointment.

News from NEI

U.S.-India joint effort targets genes and traits to improve glaucoma screening, prevention, and treatment

Researchers from the U.S. and India have begun a new collaborative project to identify genetic risk factors and traits related to glaucoma, a leading cause of blindness worldwide. Funded by the National Eye Institute (NEI), part of the National Institutes of Health (NIH), and India’s Department of Biotechnology (DBT), the researchers’ goal is to help develop effective screening, prevention, and treatment strategies for glaucoma.

English

09/29/16 5:57 am

Statement by NEI Director Paul A. Sieving, M.D., Ph.D., on National Academies’ report outlining public health strategies to promote and protect healthy vision for all Americans

Today, the National Academies of Sciences, Engineering, and Medicine (the National Academies) released “Making Eye Health A Population Health Imperative: Vision for Tomorrow.” The report culminates two years of in-depth analysis and discussion undertaken as a  consensus study on Public Health Approaches to Reduce Vision Impairment and Promote Eye Health .

09/15/16 1:07 pm

Six teams seek to identify biological factors that influence neural regeneration

The National Institutes of Health will fund six projects to identify biological factors that affect neural regeneration in the retina. The projects are part of the National Eye Institute (NEI) Audacious Goals Initiative (AGI), a targeted effort to restore vision by regenerating neurons and their connections in the eye and visual system. These projects will receive a total of $12.4 million over three years, pending availability of funds. 

08/31/16 6:38 pm

Drugs already on market prevent light-induced retinal degeneration in mice

Combinations of Food and Drug Administration-approved drugs protect against the loss of cells required for vision in a mouse model of blinding retinal diseases. The study, published in Science Signaling, was funded by the National Eye Institute, a part of the National Institutes of Health.

08/04/16 3:10 pm

Use it or Lose it: Visual Activity Regenerates Neural Connections Between Eye and Brain

A study in mice funded by the National Institutes of Health (NIH) shows for the first time that high-contrast visual stimulation can help damaged retinal neurons regrow optic nerve fibers, otherwise known as retinal ganglion cell axons. In combination with chemically induced neural stimulation, axons grew further than in strategies tried previously. Treated mice partially regained visual function. The study also demonstrates that adult regenerated central nervous system (CNS) axons are capable of navigating to correct targets in the brain.

English

07/08/16 7:05 am